Caloric needs vary significantly based on age, sex, activity level, and medical conditions
In recent years, with the continuous deepening of research on obesity and related metabolic diseases, new intestinal insulinotropic drugs including glucagon like peptide-1 (GLP-1) agonists, dual glucose dependent insulinotropic peptides (GIP), and GLP-1 receptor agonists have gradually become a research hotspot in the medical field
Melanotan 2, by contrast, demonstrates broader receptor specificity, interacting notably with the MC1, MC3, and MC4 receptors
On the other hand, traditional weight loss methods such as diet and exercise can take longer to produce results and may require more time and effort
Heightens energy expenditure Semaglutide increases energy expenditure and promotes fat burning
And finally, Srivastana does not recommend Ozempic to patients who are trying to conceive or are pregnant or breastfeeding